Periodontal Disease Predicts CAC Progression in Type 1 Diabetes

This article originally appeared here.
Share this content:
Periodontal Disease Predicts CAC Progression in Type 1 Diabetes
Periodontal Disease Predicts CAC Progression in Type 1 Diabetes

MONDAY, Aug. 31, 2015 (HealthDay News) -- In patients with type 1 diabetes, but not those without diabetes, periodontal disease duration is an independent predictor of long-term progression of coronary artery calcium (CAC), according to a study published in the Sept. 15 issue of The American Journal of Cardiology.

Daniel W. Groves, M.D., from the University of Colorado-Denver in Aurora, and colleagues examined the interrelation between periodontal disease and CAC progression in individuals with and without type 1 diabetes. The prevalence and progression of CAC was assessed in relation to self-reported periodontal disease. During a mean of 6.1 years, 473 patients with type 1 diabetes and 548 without diabetes were followed.

The researchers observed no difference in the prevalence and duration of periodontal disease at baseline for subjects with versus without diabetes (14.5 versus 13.4 percent; P = 0.60; six versus nine years; P = 0.18). There was no significant association observed between duration of periodontal disease and baseline CAC prevalence. Periodontal disease duration was significantly related to CAC progression in patients with type 1 diabetes (P = 0.004), but not in those without diabetes (P = 0.63).

"In conclusion, this study suggests that periodontal disease is an independent predictor of long-term progression of CAC in patients with type 1 diabetes," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

FDA OKs Doptelet for Liver Dz Patients Undergoing Procedures

FDA OKs Doptelet for Liver Dz Patients Undergoing ...

Doptelet reduces the need for platelet transfusion or any rescue therapy on day of procedure

Slower Decline in Lung Function With Anthocyanin Intake

Slower Decline in Lung Function With Anthocyanin Intake

Slower annual rates of decline in FEV1 and FVC for those in highest quartile of anthocyanin intake

Bioengineering Feasible for Airway Reconstruction

Bioengineering Feasible for Airway Reconstruction

Bioengineered tracheal and bronchial reconstruction reported using stented aortic matrices

is free, fast, and customized just for you!

Already a member?

Sign In Now »